MedNavigate played a pivotal role in advising on the design of multiple class 3 device clinical trials, emphasizing the inclusion of patient-centric and economic value endpoints for various. The advisory services encompassed a thorough review of company materials and external scientific publications, focusing on understanding the disease burden associated with each respective disease indication and synthesizing key findings. Additionally, a comprehensive analysis of the comparative clinical trial landscape was conducted, summarizing critical insights. Our founder, Nancy Hedlund, actively participated in multiple project team calls, contributing insights and support in discussions related to study design elements and economic strategies. The culmination of these efforts resulted in the development of a PowerPoint slide deck for each respective use case, providing a comprehensive guide for the client team to inform decision-making.
